Gene · 7376
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Apolipoproteins in the Commonest Cancers: A Review. | Cancers (Basel) | 2023 | 38067270 | PubTator, text mining | PubMed |
| The role of AMPK in macrophage metabolism, function and polarisation. | J Transl Med | 2023 | 38066566 | PubTator, text mining | PubMed |
| Danlou Recipe promotes cholesterol efflux in macrophages RAW264.7 and reverses cholesterol transport in mice with hyperlipidemia induced by P407. | BMC Complement Med Ther | 2023 | 38066464 | PubTator, text mining | PubMed |
| Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer. | J Transl Med | 2023 | 38062450 | PubTator, text mining | PubMed |
| Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing. | Front Immunol | 2023 | 38022625 | PubTator, text mining | PubMed |
| Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2. | Cell Death Dis | 2023 | 38016947 | PubTator, text mining | PubMed |
| Maladaptive T-Cell Metabolic Fitness in Autoimmune Diseases. | Cells | 2023 | 37947619 | PubTator, text mining | PubMed |
| Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis. | Cell Rep Med | 2023 | 37944529 | PubTator, text mining | PubMed |
| Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways. | Biomedicines | 2023 | 37893218 | PubTator, text mining | PubMed |
| Harnessing Oleanolic Acid and Its Derivatives as Modulators of Metabolic Nuclear Receptors. | Biomolecules | 2023 | 37892147 | PubTator, text mining | PubMed |
| Clustered and diverse transcription factor binding underlies cell type specificity of enhancers for housekeeping genes. | Genome Res | 2023 | 37884340 | PubTator, text mining | PubMed |
| Gallstone Disease and Its Correlation With Thyroid Disorders: A Narrative Review. | Cureus | 2023 | 37842424 | PubTator, text mining | PubMed |
| Robust homeostasis of cellular cholesterol is a consequence of endogenous antithetic integral control. | Front Cell Dev Biol | 2023 | 37842086 | PubTator, text mining | PubMed |
| Exploring in vitro and in silico Biological Activities of Calligonum Comosum and Rumex Vesicarius: Implications on Anticancer and Antibacterial Therapeutics. | Saudi Pharm J | 2023 | 37822695 | PubTator, text mining | PubMed |
| 25-hydroxycholesterol: an integrator of antiviral ability and signaling. | Front Immunol | 2023 | 37781400 | PubTator, text mining | PubMed |
| Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study. | Signal Transduct Target Ther | 2023 | 37752117 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37745301 | PubTator, text mining | PubMed |
| Ligand flexibility and binding pocket malleability cooperate to allow selective PXR activation by analogs of a promiscuous nuclear receptor ligand. | Structure | 2023 | 37729916 | PubTator, text mining | PubMed |
| Deciphering a shared transcriptomic regulation and the relative contribution of each regulator type through endometrial gene expression signatures. | Reprod Biol Endocrinol | 2023 | 37700285 | PubTator, text mining | PubMed |
| Association of a single nucleotide polymorphism in SOD2 with susceptibility for the development of diabetic nephropathy in patients with type 2 diabetes: A Saudi population study. | Endocrinol Diabetes Metab | 2023 | 37698290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7376/papers?page=6